ArticleSystematic reviews2025
The assessment of suicidality in psychiatric trials: a protocol for a scoping review.
Article in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSuicide is one of the leading causes of death worldwide, especially in patients with mental health disorders. Suicidality is an important outcome for patients in psychiatric randomised clinical trials. The aim of this scoping review is to assess whether and how psychiatric trials assess suicidal ideation, suicide attempts, and suicides.
methodsThis is a protocol for a scoping review. We will conduct a search of high-impact journals for randomised clinical trials published since January 2022 that include mental health patients, irrespective of the intervention type. We will assess if and how psychiatric trials assess suicidal ideation, suicide attempts, and suicides. DISCUSSION: This scoping review will be the first to examine how suicidality is assessed in contemporary randomised clinical trials. In combination with the PIO-Psych Initiative, this scoping review will ultimately guide future researchers in selecting patient-important outcomes and inform clinical research practice. However, the focus on high-impact journals may limit the generalisability of the findings. SCOPING REVIEW REGISTRATION: This scoping review is part of a project that has been prospectively registered on the COMET website ( https://comet-initiative.org/Studies/Details/3125 ).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.